TrialHematological oncology2026

Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial.

Paula de Melo Campos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.